在患有卵巢内膜异位症的患者中影响药物坚持dienogest的障碍:一种定性研究
Yihui Duan1, Chaonan Wang1, Yuyi Luo1
1School of Nursing, Shanxi Medical University, Taiyuan, China.
Frontiers in medicine
|February 16, 2026
概括
患有卵巢内膜异位症的患者因能力,机会和动机问题而面临药物坚持障碍. 了解这些因素是改善二诺日斯特治疗坚持的关键.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 卵巢内膜异位症 (OE) 是一种需要长期治疗的慢性疾病.
- 药物坚持对于有效治疗OE至关重要,特别是在使用像dienogest这样的药物时.
- 坚持治疗的障碍会对治疗结果和患者的生活质量产生重大影响.
研究的目的:
- 识别和分析卵巢内膜异位症患者的药物坚持障碍.
- 利用能力,机会,动机 - 行为 (COM-B) 模型来理解坚持挑战.
- 提出有针对性的策略,以改善OE患者的二诺基斯特坚持.
主要方法:
- 使用定向内容分析的定性研究方法.
- 与15名被诊断患有卵巢内膜异位症的患者进行了半结构面试.
- 从接受dienogest治疗超过六个月的患者收集的数据.
主要成果:
- 关于坚持障碍的三个主要主题出现了:缺乏能力,缺乏机会和患者动机不足.
- 这些主题突出了影响患者遵守药物治疗方案的能力和意愿的多方面的挑战.
- 系统地探索了患者对使用dienogest的经验和看法.
结论:
- 该COM-B模型有效地框架了卵巢内膜异位症患者的药物坚持障碍.
- 了解患者特异性障碍对于开发定制干预措施至关重要.
- 这项研究为增强二氧化物附策略和改进OE管理提供了基础.
相关概念视频
Oogenesis
70.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
301
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
301
Factors Affecting Drug Distribution: Physiological Barriers
776
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
776
Drug Dosing: Obese Patients
275
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
275
Intrauterine Drug Delivery Systems
20
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
20
Bioavailability Study Design: Healthy Subjects Versus Patients
164
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
164

